Xencor Stock Price

-1.92 (-4.71%)
Upgrade to Real-Time
Regular Market


52 Week Range


Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Xencor Inc XNCR NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-1.92 -4.71% 38.84 12:46:00
Open Price Low Price High Price Close Price Prev Close
39.55 37.47 41.82 40.76
Bid Price Ask Price Spread News
38.78 38.91 0.13 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
2,041 97,606 $ 38.87 $ 3,794,196 212,135 27.38 - 58.345
Last Trade Time Type Quantity Stock Price Currency
12:46:00 1 $ 38.84 USD

Xencor Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 2.26B 58.22M 34.09M $ 122.69M $ -83.22M -1.21 -35.20
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% 410.54k 13.30%

more financials information »

Xencor News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical XNCR Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week44.1744.6837.4742.53207,757-5.33-12.07%
1 Month42.7145.36537.4742.54198,681-3.87-9.06%
3 Months53.6458.34537.4744.78225,612-14.80-27.59%
6 Months42.9858.34537.4744.76247,811-4.14-9.63%
1 Year29.8358.34527.3838.07327,4929.0130.2%
3 Years30.3858.34519.3536.99317,2678.4627.85%
5 Years11.1858.34510.954232.48285,28327.66247.41%

Xencor Description

Xencor Inc is a clinical-stage biopharmaceutical company based in the United States. It focuses on discovering and developing engineered monoclonal antibody and other protein therapeutics to treat severe and life-threatening diseases with unmet medical needs. The company uses its XmAb technology platform to create antibody product candidates such as XmAb5871 and XmAb7195. It also has a few pre-clinical stage candidates in its portfolio such as XmAb14045 and XmAb13676. Xencor earns its revenue from research and development collaborations and licenses of its internally developed drug candidates.

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.